Pages

Sunday, June 23, 2013

Pluristem slumps as FDA suspends stem cell study Pluristem...

Pluristem said one patient in a mid-stage clinical trial suffered a severe allergic reaction to treatment and was hospitalized.

http://www.news.net/article/315115/Health/

No comments:

Post a Comment